[Nephropathy following administration of angiogenesis inhibitors]

MeSH terms

• Adult
• Angiogenesis Inhibitors / adverse effects*
• Angiogenesis Inhibitors / therapeutic use
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bevacizumab
• Bowman Capsule / blood supply
• Bowman Capsule / physiology
• Dacarbazine / administration & dosage
• Deoxycytidine / administration & dosage
• Deoxycytidine / adverse effects
• Deoxycytidine / analogs & derivatives
• Disease Progression
• Docetaxel
• Doxorubicin / administration & dosage
• Endothelium, Vascular / drug effects
• Endothelium, Vascular / physiopathology
• Fibrosarcoma / drug therapy
• Fibrosarcoma / secondary*
• Fibrosarcoma / surgery
• Gemcitabine
• Glomerulonephritis, Membranoproliferative / chemically induced*
• Humans
• Ifosfamide / administration & dosage
• Lung Neoplasms / drug therapy
• Lung Neoplasms / secondary*
• Male
• Mesna / administration & dosage
• Muscle Neoplasms / drug therapy
• Muscle Neoplasms / surgery
• Podocytes / physiology
• Proteinuria / chemically induced
• Taxoids / administration & dosage
• Vascular Endothelial Growth Factor A / antagonists & inhibitors
• Vascular Endothelial Growth Factor A / physiology